$DOUG
Douglas Elliman Inc. Stock $doug

$doug Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000187889724000018 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$285.8M	$200.2M
YoY Change	3.57%	-6.42%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$47.01M	$48.31M
YoY Change	-12.0%	-79.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.929M	$1.981M
YoY Change	-3.21%	-2.84%
% of Gross Profit
Operating Expenses	$47.01M	$48.31M
YoY Change	-12.0%	-79.58%
Operating Profit	-$3.673M	-$41.46M
YoY Change	-55.73%	74.16%
Interest Expense	$1.048M	$1.376M
YoY Change	-23.5%	138.06%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.607M	-$40.49M
YoY Change	-75.17%	74.3%
Income Tax	$173.0K	$1.195M
% Of Pretax Income
Net Earnings	-$1.664M	-$41.48M
YoY Change	-68.12%	135.33%
Net Earnings / Revenue	-0.58%	-20.71%
Basic Earnings Per Share	-$0.02	-$0.50
Diluted Earnings Per Share	-$0.02	-$0.50
COMMON SHARES
Basic Shares Outstanding	91.42M shares	91.54M shares
Diluted Shares Outstanding	83.34M shares	83.33M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$92.86M	$91.45M
YoY Change	-28.8%	-26.05%
Cash & Equivalents	$92.86M	$91.45M
Short-Term Investments
Other Short-Term Assets	$20.03M	$20.44M
YoY Change	6.25%	-11.2%
Inventory
Prepaid Expenses
Receivables	$27.50M	$19.83M
Other Receivables	$13.50M	$17.00M
Total Short-Term Assets	$161.5M	$154.8M
YoY Change	-19.61%	-21.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$38.67M	$39.75M
YoY Change	-7.06%	-74.46%
Goodwill	$32.23M	$32.23M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$1.970M	$1.950M
YoY Change	-0.25%	-86.76%
Other Assets	$6.827M	$7.093M
YoY Change	1.04%	6.94%
Total Long-Term Assets	$302.5M	$306.3M
YoY Change	-4.67%	-3.9%
TOTAL ASSETS
Total Short-Term Assets	$161.5M	$154.8M
Total Long-Term Assets	$302.5M	$306.3M
Total Assets	$463.9M	$461.1M
YoY Change	-10.46%	-10.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.725M	$5.438M
YoY Change	-44.11%	-11.92%
Accrued Expenses	$23.90M	$30.64M
YoY Change	-16.81%	17.04%
Deferred Revenue	$14.83M	$14.08M
YoY Change	62.02%	82.61%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$90.87M	$92.50M
YoY Change	-2.51%	4.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$310.0K	$119.0K
YoY Change	453.57%	-99.93%
Total Long-Term Liabilities	$310.0K	$119.0K
YoY Change	453.57%	-99.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$90.87M	$92.50M
Total Long-Term Liabilities	$310.0K	$119.0K
Total Liabilities	$266.4M	$265.3M
YoY Change	-0.85%	-0.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$90.69M	-$89.03M
YoY Change	225.72%	293.51%
Common Stock	$917.0K	$915.0K
YoY Change	3.5%	8.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$196.9M	$195.1M
YoY Change
Total Liabilities & Shareholders Equity	$463.9M	$461.1M
YoY Change	-10.46%	-10.78%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$1.664M	-$41.48M
YoY Change	-68.12%	135.33%
Depreciation, Depletion And Amortization	$1.929M	$1.981M
YoY Change	-3.21%	-2.84%
Cash From Operating Activities	$1.318M	-$27.29M
YoY Change	-84.37%	-13.57%
INVESTING ACTIVITIES
Capital Expenditures	$886.0K	$2.081M
YoY Change	-10.23%	-42.62%
Acquisitions
YoY Change
Other Investing Activities	$2.415M	-$77.00K
YoY Change	836.05%	-78.31%
Cash From Investing Activities	$1.529M	-$2.158M
YoY Change	-309.74%	-45.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.00K	$0.00
YoY Change	-8.33%	-100.0%
NET CHANGE
Cash From Operating Activities	1.318M	-$27.29M
Cash From Investing Activities	1.529M	-$2.158M
Cash From Financing Activities	-11.00K	$0.00
Net Change In Cash	2.836M	-$29.45M
YoY Change	-63.14%	-25.97%
FREE CASH FLOW
Cash From Operating Activities	$1.318M	-$27.29M
Capital Expenditures	$886.0K	$2.081M
Free Cash Flow	$432.0K	-$29.37M
YoY Change	-94.2%	-16.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	200239000	usd
CY2024Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	7750000	usd
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20618000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22235000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	164000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5438000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6136000	usd
CY2024Q1	doug	Commissions Payable Current CommissionsPayableCurrent	17935000	usd
CY2023Q4	doug	Commissions Payable Current CommissionsPayableCurrent	24561000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2271000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12912000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14081000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11234000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	24247000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20171000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	92504000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	97249000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	108196000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	110705000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	54458000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	51178000	usd
CY2024Q1	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	10000000	usd
CY2023Q4	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	0	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	119000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	133000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	265277000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	259265000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	91535412	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91535412	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87925412	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87925412	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	915000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	879000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	283223000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	279904000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89027000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47552000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	195111000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	233231000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	713000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	923000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	195824000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	234154000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	461101000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	493419000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	213982000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21298000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21239000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27016000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32295000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1981000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2039000	usd
CY2024Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	17750000	usd
CY2023Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	1210000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-41464000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23808000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1376000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1105000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-73000	usd
CY2024Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-391000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-454000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40490000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23230000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1195000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5390000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-41685000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-17840000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-210000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-216000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-41475000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-17624000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	234154000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-41685000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3355000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	195824000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	270457000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-17840000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	4221000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2823000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	251219000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-41685000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-17840000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1981000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2039000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3355000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2823000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-70000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	977000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5390000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-391000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-454000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-73000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5907000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5400000	usd
CY2024Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1304000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1428000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	4605000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	10361000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-5456000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	100000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3248000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13257000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6433000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5568000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-10641000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-14857000	usd
CY2024Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	17750000	usd
CY2023Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-2119000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2933000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-27291000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31575000	usd
CY2024Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	25000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	8000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	usd
CY2024Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	275000	usd
CY2024Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	85000	usd
CY2023Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	55000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2081000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3627000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2158000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3982000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4221000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4221000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29449000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-39778000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129517000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171382000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100068000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	131604000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91451000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Estimates and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">:</span><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Significant estimates subject to material changes in the near term include impairment charges and valuation of intangible assets. Actual results could differ from those estimates.</span></div>
CY2023Q2	doug	Dividends Common Stock Stock Percentage DividendsCommonStockStockPercentage	0.05
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-41475000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-17624000	usd
CY2024Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	0	usd
CY2024Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	0	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	307000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	307000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-41475000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-41475000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17931000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17931000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83334101	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82193761	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83334101	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82193761	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119808000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6079000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7171000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2538000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2538000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100068000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129517000	usd
CY2024Q1	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-352000	usd
CY2024Q1	doug	Alternative Investments Gain Loss AlternativeInvestmentsGainLoss	89000	usd
CY2023Q1	doug	Alternative Investments Gain Loss AlternativeInvestmentsGainLoss	-102000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	480000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	0	usd
CY2024Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-391000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-454000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	1210000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	200239000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	213982000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1163000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3794000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	8578000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	8325000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	256000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	278000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	989000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1078000	usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome	56000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	153000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	9767000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	9528000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	9096000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	8524000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2998000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	732000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y3M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M17D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0861
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0863
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	23914000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	28693000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	26155000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	23215000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	20276000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	16214000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	31048000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	169515000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	40701000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	128814000	usd
CY2024Q1	doug	Lessee Operating Lease Lease Not Yet Commenced Amount LesseeOperatingLeaseLeaseNotYetCommencedAmount	0	usd
CY2024Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	1162000	usd
CY2023Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	1162000	usd
CY2024Q1	us-gaap	Alternative Investment AlternativeInvestment	2996000	usd
CY2023Q4	us-gaap	Alternative Investment AlternativeInvestment	2821000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	8399000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	8888000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	555000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	570000	usd
CY2024Q1	us-gaap	Investments Investments	13112000	usd
CY2023Q4	us-gaap	Investments Investments	13441000	usd
CY2024Q1	us-gaap	Debt Securities Current DebtSecuritiesCurrent	1162000	usd
CY2023Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent	0	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	555000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	570000	usd
CY2024Q1	us-gaap	Long Term Investments LongTermInvestments	11395000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	12871000	usd
CY2024Q1	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-352000	usd
CY2024Q1	doug	Alternative Investments Gain Loss AlternativeInvestmentsGainLoss	89000	usd
CY2023Q1	doug	Alternative Investments Gain Loss AlternativeInvestmentsGainLoss	-102000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	480000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount	0	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	89000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-102000	usd
CY2024Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments	810000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	8399000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	8888000	usd
CY2024Q1	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	1950000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40490000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23230000	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	218000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5390000	usd
CY2024Q1	doug	Effective Income Tax Rate Reconciliation Change In Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInValuationAllowance	977000	usd
CY2023Q1	doug	Effective Income Tax Rate Reconciliation Change In Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInValuationAllowance	0	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1195000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5390000	usd
CY2024Q1	us-gaap	Revenues Revenues	200239000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-41464000	usd
CY2024Q1	doug	Adjusted Earnings Before Interest Taxes Depreciation And Amortization Attributable To Parent AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToParent	-18246000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1981000	usd
CY2024Q1	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	2081000	usd
CY2023Q1	us-gaap	Revenues Revenues	213982000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23808000	usd
CY2023Q1	doug	Adjusted Earnings Before Interest Taxes Depreciation And Amortization Attributable To Parent AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortizationAttributableToParent	-17645000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2039000	usd
CY2023Q1	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	3627000	usd
CY2024Q1	us-gaap	Escrow Deposit EscrowDeposit	35863000	usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	41338000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001878897-24-000018-index-headers.html	Edgar Link	pending
0001878897-24-000018-index.html	Edgar Link	pending
0001878897-24-000018.txt	Edgar Link	pending
0001878897-24-000018-xbrl.zip	Edgar Link	pending
a2024q1ex311.htm	Edgar Link	pending
a2024q1ex312.htm	Edgar Link	pending
a2024q4ex321.htm	Edgar Link	pending
doug-20240331.htm	Edgar Link	pending
doug-20240331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
doug-20240331_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
doug-20240331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
doug-20240331_pre.xml	Edgar Link	unprocessable
doug-20240331_def.xml	Edgar Link	unprocessable
doug-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOUG
Douglas Elliman Inc. Stock $doug

2024 Q2 Form 10-Q Financial Statement

#000187889724000018 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOUG Douglas Elliman Inc. Stock $doug

2024 Q2 Form 10-Q Financial Statement

#000187889724000018 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOUG
Douglas Elliman Inc. Stock $doug